 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

---
- ICU Medical (NASDAQ:ICUI) and Endologix (OTCMKTS:ELGXQ) are both medical companies,
  but which is the better business? We will compare the two companies based on the
  strength of their analyst recommendations, institutional ownership, profitability,
  valuation, risk, dividends and earnings. ...


Reviewing ICU Medical (NASDAQ:ICUI) and Endologix (OTCMKTS:ELGXQ)

---
- Endologix (OTCMKTS:ELGXQ) and Avinger (NASDAQ:AVGR) are both small-cap medical companies,
  but which is the superior stock? We will compare the two businesses based on the
  strength of their valuation, institutional ownership, profitability, analyst recommendations,
  earnings, dividends and risk. ...


Comparing Endologix (OTCMKTS:ELGXQ) and Avinger (NASDAQ:AVGR)

---
- Endologix (OTCMKTS:ELGXQ) and Biostage (OTCMKTS:BSTG) are both small-cap medical
  companies, but which is the better business? We will contrast the two companies
  based on the strength of their profitability, dividends, analyst recommendations,
  institutional ownership, valuation, risk and earnings. ...


Reviewing Biostage (OTCMKTS:BSTG) and Endologix (OTCMKTS:ELGXQ)

---
- Endologix (OTCMKTS:ELGXQ) and Nemaura Medical (NASDAQ:NMRD) are both small-cap medical
  companies, but which is the better investment? We will contrast the two businesses
  based on the strength of their risk, analyst recommendations, valuation, institutional
  ownership, profitability, earnings and ...


Nemaura Medical (NASDAQ:NMRD) vs. Endologix (OTCMKTS:ELGXQ) Critical Review

---
- Endologix (OTCMKTS:ELGXQ) and Arch Therapeutics (OTCMKTS:ARTH) are both small-cap
  medical companies, but which is the superior stock? We will compare the two businesses
  based on the strength of their institutional ownership, risk, earnings, dividends,
  valuation, profitability and analyst ...


Financial Survey: Endologix (OTCMKTS:ELGXQ) vs. Arch Therapeutics (OTCMKTS:ARTH)

---
- Endologix (OTCMKTS:ELGXQ) was downgraded by Zacks Investment Research from a hold
  rating to a sell rating in a note issued to investors on Monday, Zacks.com reports.
  According to Zacks, Endologix, Inc. develops, manufactures and markets products
  for the treatment ...


Endologix (OTCMKTS:ELGXQ) Stock Rating Lowered by Zacks Investment Research

---
- Endologix (OTCMKTS:ELGXQ) and NuVasive (NASDAQ:NUVA) are both medical companies,
  but which is the superior investment? We will compare the two businesses based on
  the strength of their profitability, valuation, risk, earnings, analyst recommendations,
  dividends and institutional ownership. Risk & ...


Comparing Endologix (OTCMKTS:ELGXQ) & NuVasive (OTCMKTS:NUVA)

---
- Endologix (OTCMKTS:ELGXQ) was upgraded by Zacks Investment Research from a sell
  rating to a hold rating in a report released on Tuesday, Zacks.com reports. According
  to Zacks, Endologix, Inc. develops, manufactures and markets products for the treatment
  of coronary...


Zacks Investment Research Upgrades Endologix (OTCMKTS:ELGXQ) to Hold

---
- Zacks Investment Research cut shares of Endologix (OTCMKTS:ELGXQ) from a hold rating
  to a sell rating in a research note released on Thursday, Zacks.com reports. According
  to Zacks, Endologix, Inc. develops, manufactures and markets products for the treatment
  of coronary and vascular diseases. A ...


Endologix (OTCMKTS:ELGXQ) Downgraded by Zacks Investment Research

Endologix, Inc. engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA.

Market Cap	$1.61M
Volume (M)	130,301.00
52-Wk High	$5.75
52-Wk Low	$0.06

Current Price	$0.0779
Prev Close	$0.0736
Open	$0.066
Dividend Yield	0.00%
50-Day Moving Average	$0.3546
Beta	0.68
Avg. Volume	6.42M
PE Ratio	N/A

52-Week High	$5.75
52-Week Low	$0.06
Market Capitalization	$1.61M
EPS	-$2.97
Price to Book	0.05
Revenue Per Employee	$255,895.49
Enterprise Value/EBITDA	-4.27

ELGX Endologix Inc.

About

Feed

News

Fundamentals